Is this you?
Request access for Summit Clinical Research with your @summitclinicalresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Summit Clinical Research
Unclaimed profileSMO · San Antonio, TX · ~120+ sites
Intera lens
ICP 8Lift (cardio sample) 0.86Recruit soph 0.14
Quality Scorecard (1–100)
Overall83Recruit61Ops90Sponsor92Ther95
Performance (observed)
Historical trials
636
Completed
329
Terminated/Withdrawn
80
Completion rate
80%
Active now
211
Phase 2
230
Phase 3
338
Realized enrollment
584,148
First study year
1991
Years active
35
Match confidence
high
Enrollment velocity (inf)
16,690
Therapeutic
Areas
Hepatology, MASH/MASLD, Obesity, Alzheimer's Disease
Specialties
NASH/NAFLD/Hepatology (primary), Obesity, Alzheimer's
Breadth (conditions)
1,412
Languages
English + Spanish (detected)
States
Multiple (North America, Latin America, Europe; 8 countries total)
Recruitment (web observed)
Advertises recruitment
Yes
SEO
Hepatology and NASH research expertise content
Capability notes
120+ site network; high-volume MASH trials specialist; obesity and Alzheimer's expansion; patient recruitment support integrated; operational mentoring
Relationships
Sponsors
National Cancer Institute (NCI); Pfizer; SWOG Cancer Research Network; Alliance for Clinical Trials in Oncology; Eli Lilly and Company; Hoffmann-La Roche
CROs
Holy Cross Hospital, Inc; Medpace, Inc.; Premier Research; Syneos Health; Teva Branded Pharmaceutical Products R&D, Inc.; Worldwide Clinical Trials
Owner / parent
LongueVue Capital (PE investment Oct 2022); Acquired Houston Research Institute (May 2025); Merged with Pinnacle Clinical Research (May 2026)
Funding
LongueVue Capital (PE, Oct 2022); Abacus Finance (senior debt)
Acquisitions
Founded 2018; LongueVue Capital investment (2022)
Expansion
Y (Operations in 25+ states, 6 countries)
Capacity & people
Investigators
—
Coordinators
—
CEO
Gail Hinkson
VP Clinical Ops
Unknown
VP Site Ops
Brandon Early, MS (President)
VP Recruitment
Unknown
Emails
Unknown
Tech & DCT
eSource
Yes
Builds tech
Unknown
DCT / decentralized
Y (100+ sites worldwide, 25+ states)
Tech stack
Unknown
Recruiting visible
Y
Notes
Large integrated research organization (120+ sites across 8 countries); PE-backed with acquisition momentum (HRI, Pinnacle merger); deep expertise in complex high-enrollment therapies (MASH/obesity/Alzheimer's); proven patient recruitment model; strong operational support; strong Intera fit—multi-site, recruitment-focused, innovation-oriented, growth trajectory.
Recommendation features (sample indication)
Ind fit 1.00Liftability 0.86Overall83
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.